N
News Analysis
manilatimes.net

www.manilatimes.net ·

Olumsuz

theolytics announces first patient dosed in the octopod ip trial a us phase 1 trial with theo 260 a novel oncolytic immunotherapy targeting ovarian cancer

WB_678_DIGITAL_GOVERNMENTWB_694_BROADCAST_AND_MEDIAWB_133_INFORMATION_AND_COMMUNICATION_TECHNOLOGIESTAX_FNCACT_CEO

manilatimes.net sitesinde haberin tamamını oku

Haberin tamamı orijinal yayıncı sitesinde. Burada sadece başlık ve çok kısa özet gösterilir.

theolytics announces first patient dosed in the octopod ip trial a us phase 1 trial with theo 260 a novel oncolytic immunotherapy targeting ovarian cancer | manilatimes.net — News Analysis